UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 62

Sortiert nach

Second-line chemotherapy versus supportive cancer treatment in advanced gastric cancer: a meta-analysis

Annals of oncology, 2013-11, Vol.24 (11), p.2850-2854

2013

Volltextzugriff (PDF)

718 Tumor response assessment by measuring the single largest lesion per organ in patients with metastatic cancer

European journal of cancer (1990), 2015-09, Vol.51, p.S132-S133

2015

Volltextzugriff (PDF)

Influence of the contact angle of silica nanoparticles at the air-water interface on the mechanical properties of the layers composed of these particles

Molecular physics, 2011-04, Vol.109 (7-10), p.1057-1066

2011

Volltextzugriff (PDF)

Efficacy of metronomic chemotherapy with oral cyclophosphamide and methotrexate in patients with non-Hodgkin lymphoma: A retrospective analysis

European journal of cancer (1990), 2016-12, Vol.69, p.S114-S115

2016

Volltextzugriff (PDF)

Investigation on Korean gastric tumorigenesis by performing whole transcriptome and miRNA sequence analysis

European journal of cancer (1990), 2016-07, Vol.61, p.S32-S33

2016

Volltextzugriff (PDF)

Effect of hydrophobicity on tensile rheological properties of silica nanoparticle monolayers at the air–water interface

Colloids and surfaces. A, Physicochemical and engineering aspects, 2012-02, Vol.395, p.262-266

2012

Volltextzugriff (PDF)

1312 Changes of quality of life in elderly gastrointestinal cancer patients after curative surgery in South Korea

European journal of cancer (1990), 2015-09, Vol.51, p.S191-S192

2015

Volltextzugriff (PDF)

A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial

Annals of oncology, 2021-03, Vol.32 (3), p.368-374

2021

Volltextzugriff (PDF)

6505 ORAL Update of AMC 0101 Study – a Randomized Phase III Trial of Intraperitoneal Cisplatin and Early Mitomycin-C Plus Long-term Doxifluridine Plus Cisplatin (iceMFP) Versus Mitomycin-C Plus Short-Term Doxifluridine (Mf) as Postoperative Adjuvant Chemotherapy for Grossly Serosa-positive Advanced Gastric Cancer (NCT00296322)

European journal of cancer (1990), 2011, Vol.47, p.S443-S444

2011

Volltextzugriff (PDF)

6570 POSTER Update of AMC 0201 Study – a Randomized Phase III Trial Comparing Mitomycin-C Plus Short-term Doxifluridine (Mf) Versus Mitomycin-C Plus Long-term Doxifluridine Plus Cisplatin (MFP) After Curative Resection of Advanced Gastric Cancer (NCT00296335)

European journal of cancer (1990), 2011, Vol.47, p.S462-S462

2011

Volltextzugriff (PDF)

Patterns of treatment outcomes in older patients with metastatic pancreatic cancer

Annals of oncology, 2017-11, Vol.28, p.x68-x68

2017

Volltextzugriff (PDF)

1246P Multicenter phase Ib/II study of second-line varlitinib and paclitaxel in patients with EGFR/HER2 co-expressing advanced gastric cancer (K-MASTER-13)

Annals of oncology, 2022-09, Vol.33, p.S1118

2022

Volltextzugriff (PDF)

Tepotinib inhibits the epithelial-mesenchymal transition and tumour growth of gastric cancers via decreasing MUC5B, MMP7, and COX2

Annals of oncology, 2019-11, Vol.30, p.vii10

2019

Volltextzugriff (PDF)

PB1880 ALTERATIONS OF UBC, GRB2, CREBBP AND GAB2 ARE OBSERVED ONLY IN ASIAN CLL: A METHYLATION BINDING DOMAIN SEQUENCING STUDY

HemaSphere, 2019-06, Vol.3 (S1), p.856-857

2019

Volltextzugriff (PDF)

446P A prospective study for real-world data (RWD) of ramucirumab plus paclitaxel in patients with locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma (KCSG ST21-06)

Annals of oncology, 2024-06, Vol.35, p.S179-S179

2024

Volltextzugriff (PDF)

50P Comparison of pelitinib, tepotinib, and docetaxel efficacy according to the copy number or gene alteration status of the EGFR, MET, HRAS, KRAS, and NRAS genes

ESMO open, 2024-02, Vol.9, p.102279, Article 102279

2024

Volltextzugriff (PDF)

708P Final clinical outcomes of nationwide precision oncology pilot study; KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors (KOSMOS) KCSG AL-20-05

Annals of oncology, 2023-10, Vol.34, p.S490-S491

2023

Volltextzugriff (PDF)

36P Comparison of pelitinib, tepotinib or docetaxel efficacy according to the copy number or gene alteration status of EGFR, MET, HRAS, KRAS and NRAS genes

ESMO open, 2023-10, Vol.8 (1), p.101682, Article 101682

2023

Volltextzugriff (PDF)

1374P A randomized phase III study to compare efficacy and safety between combination therapy and monotherapy as first-line chemotherapy in elderly patients with advanced gastric cancer (KCSG ST13-10)

Annals of oncology, 2021-09, Vol.32, p.S1041-S1041

2021

Volltextzugriff (PDF)

Phase 2 study of triplet chemotherapy with oxaliplatin, irinotecan and S-1 (OIS) as first-line treatment in patients with advanced biliary tract cancer (BTC)

Annals of oncology, 2017-09, Vol.28, p.v244-v245

2017

Volltextzugriff (PDF)

Updated results of a phase II study of gemcitabine, erlotinib, and S-1 in patients with advanced pancreatic cancer

Annals of oncology, 2017-09, Vol.28, p.v259-v259

2017

Volltextzugriff (PDF)

Comparison of two different S-1 plus cisplatin dosing schedules as first-line chemotherapy for metastatic and/or recurrent gastric cancer: a multicenter, randomized phase III trial (SOS)

Annals of oncology, 2015-10, Vol.26 (10), p.2097-2101

2015

Volltextzugriff (PDF)

Influence of enzyme and transporter polymorphisms on trough imatinib concentration and clinical response in chronic myeloid leukemia patients

Annals of oncology, 2013-03, Vol.24 (3), p.756-760

2013

Volltextzugriff (PDF)

Phase III randomized study of neoadjuvant chemotherapy (CT) with docetaxel(D), oxaliplatin(O) and S-1(S) (DOS) followed by surgery and adjuvant S-1, vs surgery and adjuvant S-1, for resectable advanced gastric cancer (GC) (PRODIGY)

Annals of oncology, 2019-10, Vol.30, p.v876-v877

2019

Volltextzugriff (PDF)

LBA41 - Phase III randomized study of neoadjuvant chemotherapy (CT) with docetaxel(D), oxaliplatin(O) and S-1(S) (DOS) followed by surgery and adjuvant S-1, vs surgery and adjuvant S-1, for resectable advanced gastric cancer (GC) (PRODIGY)

Annals of oncology, 2019-10, Vol.30, p.v876-v877

2019

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(60)

Publikationsform

Sprache

Englisch
(62)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(13)
Hematology, Oncology And Palliative Medicine
(10)
Life Sciences & Biomedicine
(9)
Humans
(7)
Oncology
(7)
Male
(5)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(4)
Physical Sciences
(4)
Adult
(3)
Aged
(3)
Animals
(3)
Antineoplastic Agents
(3)
Biological And Medical Sciences
(3)
Chemistry
(3)
Chemotherapy
(3)
Female
(3)
Medical Sciences
(3)
Middle Aged
(3)
Neoplasm Staging
(3)
Optical Waveguides
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Annals Of Oncology
(27)
European Journal Of Cancer
(8)
Esmo Open
(3)
Blood
(2)
European Journal Of Cancer Supplements
(2)
Hemasphere
(2)
Ieee Photonics Technology Letters
(2)
Leukemia Research
(2)
Animal Cells And Systems
(1)
Cancer Research
(1)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Second-line chemotherapy versus supportive cancer treatment in advanced gastric cancer: a meta-analysis

718 Tumor response assessment by measuring the single largest lesion per organ in patients with metastatic cancer

Influence of the contact angle of silica nanoparticles at the air-water interface on the mechanical properties of the layers composed of these particles

Efficacy of metronomic chemotherapy with oral cyclophosphamide and methotrexate in patients with non-Hodgkin lymphoma: A retrospective analysis

Investigation on Korean gastric tumorigenesis by performing whole transcriptome and miRNA sequence analysis

Effect of hydrophobicity on tensile rheological properties of silica nanoparticle monolayers at the air–water interface

1312 Changes of quality of life in elderly gastrointestinal cancer patients after curative surgery in South Korea

A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial

6570 POSTER Update of AMC 0201 Study – a Randomized Phase III Trial Comparing Mitomycin-C Plus Short-term Doxifluridine (Mf) Versus Mitomycin-C Plus Long-term Doxifluridine Plus Cisplatin (MFP) After Curative Resection of Advanced Gastric Cancer (NCT00296335)

Patterns of treatment outcomes in older patients with metastatic pancreatic cancer

1246P Multicenter phase Ib/II study of second-line varlitinib and paclitaxel in patients with EGFR/HER2 co-expressing advanced gastric cancer (K-MASTER-13)

Tepotinib inhibits the epithelial-mesenchymal transition and tumour growth of gastric cancers via decreasing MUC5B, MMP7, and COX2

PB1880 ALTERATIONS OF UBC, GRB2, CREBBP AND GAB2 ARE OBSERVED ONLY IN ASIAN CLL: A METHYLATION BINDING DOMAIN SEQUENCING STUDY

446P A prospective study for real-world data (RWD) of ramucirumab plus paclitaxel in patients with locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma (KCSG ST21-06)

50P Comparison of pelitinib, tepotinib, and docetaxel efficacy according to the copy number or gene alteration status of the EGFR, MET, HRAS, KRAS, and NRAS genes

708P Final clinical outcomes of nationwide precision oncology pilot study; KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors (KOSMOS) KCSG AL-20-05

36P Comparison of pelitinib, tepotinib or docetaxel efficacy according to the copy number or gene alteration status of EGFR, MET, HRAS, KRAS and NRAS genes

1374P A randomized phase III study to compare efficacy and safety between combination therapy and monotherapy as first-line chemotherapy in elderly patients with advanced gastric cancer (KCSG ST13-10)

Phase 2 study of triplet chemotherapy with oxaliplatin, irinotecan and S-1 (OIS) as first-line treatment in patients with advanced biliary tract cancer (BTC)

Updated results of a phase II study of gemcitabine, erlotinib, and S-1 in patients with advanced pancreatic cancer

Comparison of two different S-1 plus cisplatin dosing schedules as first-line chemotherapy for metastatic and/or recurrent gastric cancer: a multicenter, randomized phase III trial (SOS)

Influence of enzyme and transporter polymorphisms on trough imatinib concentration and clinical response in chronic myeloid leukemia patients

Phase III randomized study of neoadjuvant chemotherapy (CT) with docetaxel(D), oxaliplatin(O) and S-1(S) (DOS) followed by surgery and adjuvant S-1, vs surgery and adjuvant S-1, for resectable advanced gastric cancer (GC) (PRODIGY)

LBA41 - Phase III randomized study of neoadjuvant chemotherapy (CT) with docetaxel(D), oxaliplatin(O) and S-1(S) (DOS) followed by surgery and adjuvant S-1, vs surgery and adjuvant S-1, for resectable advanced gastric cancer (GC) (PRODIGY)

Suchergebnisse filtern